In choppy trade, the BSE index opened better but dropped to a low of 28,435.45 on profit-booking. However, it quickly bounced back to hit a high of 28,784.35 and settled for the day at 28,736.38 -- a gain of 298.67 points, or 1.05 per cent.
The surge comes after the barometer lost 492.70 points in the previous two sessions after rising inflation dashed hopes of aggressive rate cuts by the RBI.
The 50-share NSE index Nifty reclaimed the 8,700-mark by rising 90.15 points, or 1.04 per cent, to close at 8,723.30 after shuttling between 8,742.55 and 8,630.80 intra-day.
Last week markets were spooked on speculation US Federal Reserve will in its policy meeting starting soon drop hints of an early rate hike, which could come as early as June-July. However, that buzz eased after tepid US manufacturing data. The Fed's 2-day monetary policy meeting begins Tuesday.
"Pharma and metal stocks helped indices rise and better trend in in global markets further strengthened domestic markets," said Delhi-based stock broker Deepak Pahwa.
Among pharma stocks, Dr Reddy's climbed 3.66 per cent, Cipla jumped 2.11 per cent and Sun Pharma gained 1.12 percent.
Investors, after remaining sellers in the past few sessions, were seen accumulating stocks, brokers said.
A higher opening in the Europe following overnight rally on the US markets boosted sentiments, they added.
Other Sensex-based gainers which provided support include Hindalco, Sesa Sterlite, HDFC, Tata Motors, BHEL, L&T, Axis Bank, Tata Steel, RIL, ITC, M&M, NTPC and ICICI Bank.
Meanwhile, foreign investors sold shares worth Rs 762.55 crore yesterday as per provisional data.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
